InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, held its 16th Annual Internal Scientific Meeting. The Meeting combined a warm and welcoming atmosphere with insightful discussions on key priorities and future opportunities, strengthening the team's strong engagement and collaborative spirit.
Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, opened the Meeting by the overview of InSysBio’s recent achievements, projects and organizational changes. Through collaborations with leading pharmaceutical companies and cutting-edge biotech innovators in 2025, InSysBio has advanced the application of QSP modeling to support drug development and decision-making. InSysBio focused on such therapeutic areas as oncology, immune-oncology, immunology & inflammation, neurodegenerative diseases and rare diseases.
The meeting featured a review of InSysBio's 2025 performance, during which team members highlighted their key contributions to ongoing projects. The presentations concluded with an engaging discussion on the company's future outlook, strategic priorities, and opportunities for continued growth.
Moreover, InSysBio’s own fully-fledged QSP infrastructure that includes QSP softs (Heta, Likelihood Profiler), databases (CYTOCON DB, fIVE DB) and Cloud infrastructure for multiple simulations were significantly enhanced throughout the year and further update is underway. In 2025 InSysBio presented its QSP modeling services and software to optimize drug development at AACR, PAGE, JuliaCon Paris, BioTechX Europe, and ACoP.
Looking ahead, InSysBio remains focused on sustainable development and innovation. This year InSysBio has already presented its results at AGAH Conference, QSPC, ChinaBio and is going to participate in SITC and ACoP 2026.
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio's cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | March 2017 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
|
4
|
5
| ||
|
6
|
7
|
8
|
9
1.
09 Mar 2017 14:10
ISBM Enclosed Conference was held
20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
|
10
|
11
|
12
|
|
13
|
14
|
15
1.
15 Mar 2017 11:49
Institute for Systems Biology participates in American Society for Clinical Pharmacology and Therapeutics 2017 Meeting
Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT).
|
16
|
17
|
18
|
19
|
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
|
27
|
28
1.
28 Mar 2017 17:56
Not all therapies are effective: Institute for Systems Biology Moscow to present the results of the Alzheimer’s disease Systems Pharmacology Modeling
Moscow, Russia – March 28, 2017. On the 1st April, Tatyana Karelina, ISBM leading specialist in neurodegenerative field, will present a poster entitled "Amyloid toxicity and different mechanisms of action for amyloid-targeted treatments studied by quantitative systems pharmacology model" at the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders to be held on March 29 - April 2, Vienna, Austria.
|
29
|
30
|
31
| ||
Thank you for your message! We will get back to you shortly.
